Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 20 (7), 1176-82

Undiagnosed Acute Viral Febrile Illnesses, Sierra Leone

Undiagnosed Acute Viral Febrile Illnesses, Sierra Leone

Randal J Schoepp et al. Emerg Infect Dis.

Abstract

Sierra Leone in West Africa is in a Lassa fever-hyperendemic region that also includes Guinea and Liberia. Each year, suspected Lassa fever cases result in submission of ≈500-700 samples to the Kenema Government Hospital Lassa Diagnostic Laboratory in eastern Sierra Leone. Generally only 30%-40% of samples tested are positive for Lassa virus (LASV) antigen and/or LASV-specific IgM; thus, 60%-70% of these patients have acute diseases of unknown origin. To investigate what other arthropod-borne and hemorrhagic fever viral diseases might cause serious illness in this region and mimic Lassa fever, we tested patient serum samples that were negative for malaria parasites and LASV. Using IgM-capture ELISAs, we evaluated samples for antibodies to arthropod-borne and other hemorrhagic fever viruses. Approximately 25% of LASV-negative patients had IgM to dengue, West Nile, yellow fever, Rift Valley fever, chikungunya, Ebola, and Marburg viruses but not to Crimean-Congo hemorrhagic fever virus.

Keywords: ELISA; IgM; Lassa virus; Sierra Leone; West Africa; arthropod-borne; diagnostics; febrile; hemorrhagic fever; immunodiagnostics; serologic; undiagnosed; vector-borne infections; viruses.

Figures

Figure
Figure
Lassa fever–hyperendemic region (white area) comprising parts of Guinea, Sierra Leone, and Liberia in West Africa. Insert image: Lassa Diagnostic Laboratory, Kenema Government Hospital, Kenema, Sierra Leone.

Similar articles

See all similar articles

Cited by 42 PubMed Central articles

See all "Cited by" articles

References

    1. McCormick JB, Webb PA, Krebs JW, Johnson KM, Smith ES. A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis. 1987;155:437–44 10.1093/infdis/155.3.437 - DOI - PubMed
    1. Hadi CM, Goba A, Khan SH, Bangura J, Sankoh M, Koroma S, et al. Ribavirin for Lassa fever postexposure prophylaxis. Emerg Infect Dis. 2010;16:2009–11 10.3201/eid1612.100994 - DOI - PMC - PubMed
    1. Branco LM, Boisen ML, Andersen KG, Grove JN, Moses LM, Muncy IJ, et al. Lassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: case report. [Erratum in: Virol J. 2011;8:480. ] Virol J. 2011;8:404 10.1186/1743-422X-8-404 - DOI - PMC - PubMed
    1. Grove JN, Branco LM, Boisen ML, Muncy IJ, Henderson LA, Schieffellin JS, et al. Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: case report. Virol J. 2011;8:314–27 10.1186/1743-422X-8-314 - DOI - PMC - PubMed
    1. Branco LM, Grove JN, Boisen ML, Shaffer JG, Goba A, Fullah M, et al. Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection. Virol J. 2011;8:478 10.1186/1743-422X-8-478 - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources

Feedback